Ethex recalls single lot of morphine
Oversized morphine sulfate tablet leads to recall.
A report of a tablet twice its normal size has resulted in a recall of one lot of morphine sulfate 60-mg extended-release tablets (Lot No. 91762) by Ethex Corp. According to the company, the affected lot was distributed between April 16 and April 27, 2008, and may contain as much as twice the normal amount of morphine sulfate. However, there have been no side effects or injuries reported. No other dosage forms or any other lots of product are affected. Questions about the recall should be directed to Ethex Customer Service at 1-(800)-321-1705. E-mail may be sent to customer-service@ethex.com.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
